Latham, Cooley Lead Cargo Therapeutics $281M IPO
Cancer-focused biotechnology firm Cargo Therapeutics Inc. on Thursday priced a $281.3 million initial public offering at the bottom of its range, represented by Latham & Watkins LLP and underwriters counsel Cooley...To view the full article, register now.
Already a subscriber? Click here to view full article